Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders.
about
Ibrutinib: Implications for Use in the Treatment of Mantle Cell Lymphoma and Chronic Lymphocytic LeukemiaRole of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell NeoplasmsTen things you should know about protein kinases: IUPHAR Review 14Identification of protein kinase inhibitors with a selective negative effect on the viability of Epstein-Barr virus infected B cell linesDiscovery of Potent and Selective Tricyclic Inhibitors of Bruton's Tyrosine Kinase with Improved Druglike Properties.B-cell receptor signaling as a driver of lymphoma development and evolution.Inhibitors of BTK and ITK: state of the new drugs for cancer, autoimmunity and inflammatory diseases.Bruton's tyrosine kinase mediates the synergistic signalling between TLR9 and the B cell receptor by regulating calcium and calmodulinRole of Bruton's tyrosine kinase inhibitors in HIV-1-infected cellsBCR signaling in chronic lymphocytic leukemia and related inhibitors currently in clinical studies.B-lymphocyte tolerance and effector function in immunity and autoimmunity.Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases.Emerging immunological drugs for chronic lymphocytic leukemia.Pharmacodynamic considerations of small molecule targeted therapy for treating B-cell malignancies in the elderly.Oxindole-based SYK and JAK3 dual inhibitors for rheumatoid arthritis: designing, synthesis and biological evaluation.Versican G1 domain enhances adenoviral-mediated transgene expression and can be modulated by inhibitors of the Janus kinase (JAK)/STAT and Src family kinase pathways.The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.Bruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer Cells.Multiple signals at the extended 8p23 locus are associated with susceptibility to systemic lupus erythematosus.Bruton tyrosine kinase (Btk) suppresses osteoblastic differentiation.A specific PTPRC/CD45 phosphorylation event governed by stem cell chemokine CXCL12 regulates primitive hematopoietic cell motilityDrug-Target Kinetics in Drug Discovery.Spleen Tyrosine Kinase Inhibitors (SYK) as Potential Treatment for Autoimmune and Inflammatory Disorders: Patent HighlightA Pyrazolo[3,4-d]pyrimidine Compound Reduces Cell Viability and Induces Apoptosis in Different Hematological Malignancies.Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib.Bruton's Tyrosine Kinase Deficiency Inhibits Autoimmune Arthritis in Mice but Fails to Block Immune Complex-Mediated Inflammatory Arthritis.Ligand-based and e-pharmacophore modeling, 3D-QSAR and hierarchical virtual screening to identify dual inhibitors of spleen tyrosine kinase (Syk) and janus kinase 3 (JAK3).
P2860
Q26749010-49482946-43B0-4735-B8C5-AA64AAE0BBA2Q26795594-28759E1B-9FC3-4231-9627-9DB11BC70A5EQ26849417-B2FC5A2D-8848-4B60-9705-9B6699E02C37Q31159325-AD818AB0-3D2E-4B32-8DD6-D4167767BC7FQ33786371-8B3F01DD-5F2A-429D-8E32-9ED66D8E9B29Q34398579-F5E9317A-629B-4EB4-8A14-F9760D2F5CD7Q34722000-D7A1BA46-DF63-4103-BCD8-6F4E185F6333Q34965726-7FAD3F01-3901-4DAC-B234-2E0E7C773C37Q35612194-588FE0E8-7D85-4297-9806-8D2B06B9610EQ38101590-6CA74027-CC5F-4C54-A6F8-A147CC2AFBECQ38167667-28647DBC-0DEA-4F93-87F5-DE7C079376CEQ38169198-76D518B2-AD36-4851-859F-AD3214810808Q38543771-4765F6C2-CAEC-4D78-BEC6-FCD7E0489A5FQ38544216-98D4DB0A-DB40-4FF6-886E-AD8EC2552281Q38655324-41FEB496-816E-46D5-AAA6-377CAC5CE418Q38690392-EC622193-29BC-46C8-A59D-6DE99B758BD3Q38728631-763D1E80-4B2A-4C25-9F0D-064216391592Q38766891-5687D88E-DD7A-46B5-A42D-3FEDAF74B7B2Q38910405-BEE72AD0-9467-40C1-96D4-9398E219EBBBQ38955617-45156E22-3AF7-4E7C-A326-11D589344127Q39101349-02FDDF09-153E-47D2-8800-046560DFE00BQ39391104-AB317174-CBCF-41B0-8B1A-EB4AEFC89B85Q39777668-763DF92F-9EAA-4BE6-8EE4-E033B6CC5DE2Q41811693-51CCF19B-AE9B-42E9-81C1-FB47C739AF4DQ42397466-E3A36D1F-C068-4E13-BAF8-C7D0A8BDFD1BQ46333548-4951470F-C4D1-4E1E-B513-8FB4334C1AB1Q54172917-951391F7-F3B7-420D-8A64-4839212D0572
P2860
Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tyrosine kinase inhibitors as ...... cies and autoimmune disorders.
@en
type
label
Tyrosine kinase inhibitors as ...... cies and autoimmune disorders.
@en
prefLabel
Tyrosine kinase inhibitors as ...... cies and autoimmune disorders.
@en
P2860
P1476
Tyrosine kinase inhibitors as ...... cies and autoimmune disorders.
@en
P2093
Tadeusz Robak
P2860
P304
P356
10.1517/13543784.2012.685650
P407
P577
2012-05-22T00:00:00Z